by Jason Heaviland | Sep 24, 2025 | Uncategorized
Why Strategic Sample Management Matters The samples arriving at research laboratories today might tell stories that won’t be fully understood for months or even years, given the inherently gradual nature of scientific insight where hypotheses evolve, promising...
by ODWAdmin | Sep 24, 2025 | Uncategorized
Proteolysis Targeting Chimeras (PROTACs) have fundamentally transformed our approach to targeted therapeutics, offering a paradigm shift from traditional protein inhibition to selective protein degradation. These hetero-bifunctional molecules hijack the ubiquitin...
by ODWAdmin | Sep 22, 2025
Comprehensive Biological Profiling in Cancer via Multi-Omics Integration Colorectal cancer is on the rise and remains difficult to detect and treat. Panome Bio’s multi-omics platform combines metabolomics and proteomics to reveal how molecules interact across...
by ODWAdmin | Sep 21, 2025 | Uncategorized
Proteolysis-targeting chimeras (PROTACs) have emerged as a transformative approach in drug discovery, offering event-driven protein degradation mechanisms that overcome limitations of traditional occupancy-driven inhibitors. While conventional small-molecule PROTACs...
by Jason Heaviland | Sep 19, 2025 | Uncategorized
The LNP Formulation Dilemma: How Multi-Omics Reveals Which Lipids Actually Work Your lipid nanoparticle formulation screen includes twenty candidates. Each varies in ionizable lipid structure, PEG-lipid ratio, or helper lipid composition. Standard metrics show they...
